Pulmonary rehabilitation for patients with COPD in rural areas
Official title: Decreasing Disparity in Lung Disease: Pulmonary Rehabilitation for Rural Patients With COPD
Run by Mayo Clinic · NCT06847061 · Data updated 2026-11-12
This study is testing a special rehabilitation program for people with COPD living in rural areas to see if it helps them breathe better and improves their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 306 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 2 sites (Scottsdale, Arizona and 1 other locations) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | August 31, 2029 |
| Study ends | August 31, 2029 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT06847061 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 40 and older with a physician-diagnosed COPD who reside in rural areas.
✕Probably not a fit
Patients who are unable to walk due to orthopedic, neurologic, or cardiac limitations, or those with no significant COPD symptoms, are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the uptake and effectiveness of a pulmonary rehabilitation program specifically designed for patients with Chronic Obstructive Pulmonary Disease (COPD) living in rural areas. It will assess the experiences of patients, caregivers, and healthcare providers involved in the program. The intervention focuses on providing essential rehabilitation services that are often lacking in these regions, with the goal of improving patient outcomes and quality of life.
Why it matters
Potential benefit: If successful, this program could significantly enhance the health and well-being of rural patients suffering from COPD.
How similar studies have gone: Other studies have shown positive outcomes with pulmonary rehabilitation programs, particularly in urban settings, but this approach in rural areas is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * 40 years of age or older * Physician-diagnosed COPD * Living in a rural area defined by Rural-Urban Commuting Area Codes 4-10 * mMRC score\>=1 * English Speaking Exclusion Criteria * Inability to walk (orthopedic/neurologic/cardiac limitation causing immobility) * Cognitive impairment or inability to understand and follow instructions. * Patients with no COPD symptom burden, no breathlessness (mMRC score 0), as based on our previous studies they usually perceive no benefit from PR and do not have compliance with PR. * Traditional center-based PR was completed within 3 months of initial study recruitment. * Transition to hospice or end-of-life care at the time of screening. * Acute exacerbation at the time of screening.
Where it's running
-
Mayo Clinic in Arizona
Scottsdale, Arizona, United States Recruiting -
Mayo Clinic in Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Roberto Benzo, M.D. — Mayo Clinic
- Study coordinator: Johanna Hoult, M.A.
- Email: Hoult.Johanna@mayo.edu
- Phone: 507-293-1989
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
IOS-based platform to screen, diagnose, and manage COPD and asthma
This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.
-
Targeted NMES to improve breathing and leg/extra muscle strength in COPD
This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
PBMT with a pulmonary rehab program for COPD patients
A small randomized trial tests whether adding photobiomodulation therapy before exercise in a COPD pulmonary rehab program helps improve functional capacity.
-
Controlled versus standard oxygen therapy for ICU COPD with acute exacerbation
This trial tests whether keeping oxygen levels at 88-92% helps ICU patients with an acute COPD flare more than keeping levels above 94%.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.